Oseltamivir-Induced Mania in a Patient With Influenza A

被引：2

作者：

Ferahkaya, Eda ^{[1
]}

机构：

[1] Univ Hlth Sci, Konya Training & Res Hosp, Dept Psychiat, Hacisaban Mah,Yeni Meram Caddesi 97, TR-42090 Meram, Konya, Turkey

来源：

CLINICAL NEUROPHARMACOLOGY | 2021年 / 44卷 / 03期

关键词：

mania; oseltamivir; influenza; COVID-19; NEUROPSYCHIATRIC ADVERSE EVENTS; TAMIFLU; SAFETY;

D O I：

10.1097/WNF.0000000000000446

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Oseltamivir is an antiviral drug often preferred in treating viral infections. Its use has increased owing to annual influenza outbreaks and the COVID-19 pandemic. Although its adverse effects are often seen in the gastrointestinal system, it has other adverse effects that can prevent its use, for example, neuropsychiatric events. In this case report, we present a manic episode case caused by the use of oseltamivir.

引用

页码：106 / 107

页数：2

共 19 条

[1] Oseltamivir (Tamiflu) Induced Depressive Episode in a Female Adolescent [J].

Chung, Sungho ;

Joung, Yoo Sook .

PSYCHIATRY INVESTIGATION, 2010, 7 (04) :302-304

[2] Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 20072010 [J].

Greene, Sharon K. ;

Li, Lingling ;

Shay, David K. ;

Fry, Alicia M. ;

Lee, Grace M. ;

Jacobsen, Steven J. ;

Baxter, Roger ;

Irving, Stephanie A. ;

Jackson, Michael L. ;

Naleway, Allison L. ;

Nordin, James D. ;

Narwaney, Komal J. ;

Lieu, Tracy A. .

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 (04) :335-344

[3] Inhibition of MAO-A and stimulation of behavioural activities in mice by the inactive prodrug form of the anti-influenza agent oseltamivir [J].

Hiasa, Miki ;

Isoda, Yumiko ;

Kishimoto, Yasushi ;

Saitoh, Kenta ;

Kimura, Yasuaki ;

Kanai, Motomu ;

Shibasaki, Masakatsu ;

Hatakeyama, Dai ;

Kirino, Yutaka ;

Kuzuhara, Takashi .

BRITISH JOURNAL OF PHARMACOLOGY, 2013, 169 (01) :115-129

[4] Oseltamivir-Induced Mania in a Patient With H1N1 [J].

Ho, Lily N. L. ;

Chung, Joseph P. Y. ;

Choy, Karen L. W. .

AMERICAN JOURNAL OF PSYCHIATRY, 2010, 167 (03) :350-350

[5]

Huang YJ., 2018, PRIM CARE COMPANION, V20

[6] Neuroexcitatory actions of Tamiflu and its carboxylate metabolite [J].

Izumi, Yukitoshi ;

Tokuda, Kazuhiro ;

O'Dell, Kazuko A. ;

Zorumski, Charles F. ;

Narahashi, Toshio .

NEUROSCIENCE LETTERS, 2007, 426 (01) :54-58

[7]

Jamieson B, 2009, CAN FAM PHYSICIAN, V55, P1199

[8] Blood-brain barrier imaging as a potential biomarker for bipolar disorder progression [J].

Kamintsky, Lyna ;

Cairns, Kathleen A. ;

Veksler, Ronel ;

Bowen, Chris ;

Beyea, Steven D. ;

Friedman, Alon ;

Calkin, Cynthia .

NEUROIMAGE-CLINICAL, 2020, 26

[9] Risk of neuropsychiatric adverse events associated with the use of oseltamivir: a nationwide population-based case-crossover study [J].

Kang, Hye-Rim ;

Lee, Eui-Kyung ;

Kim, Woo Jung ;

Shin, Ju-Young .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (02) :453-461

[10] Mania in a Patient With H1N1: Is Oseltamivir the Culprit or a Red Herring? [J].

Khandaker, Gulam Mustofa ;

Khandaker, Golam Mohammed ;

Dibben, Claire ;

Zurynski, Yvonne ;

Elliott, Elizabeth J. ;

Booy, Robert .

AMERICAN JOURNAL OF PSYCHIATRY, 2010, 167 (09) :1129-1130

← 1 2 →